Current & Critical - Philippe Lucas, The Evolution of the Psychedelic Therapy Sector

In this episode, the President of Sabi Mind, Philippe Lucas, shares insights on a common analgesic’s potential in treating mental health issues. He explains how it can help reduce trauma responses, suicidal ideation, anxiety, lack of connectedness, and depression. Sabi Mind is expanding from Calgary to Edmonton and Victoria to provide access to communities with limited exposure to psychedelic medicine. You’ll learn about ketamine’s therapeutic effects in a clinical setting, Sabi Mind’s innovative psilocybin study for alcohol use disorder treatment, and much more. Join us for a fascinating conversation on the promising developments in psychedelic medicine.

Philippe Lucas is a medical cannabis pioneer who opened one of the first cannabis stores in Vancouver in 1999; he has long recognized the power of psychedelic medicines for healing and transformation. He shares his insights on how rapid research is changing the public health approach to altering consciousness. Philippe highlights some impressive data from Sabi Mind’s ketamine trials and its potential to treat various mental health issues. He also discusses how Sabi Mind has created a Wellness Fund to provide accessible treatment to patients in need plus the importance of collaboration between practitioners in leading the psychedelic revolution in Calgary. Tune in for a glimpse into Sabi Mind’s groundbreaking work!